GeneNews Ltd (TSE:GEN – Get Free Report) shares rose 7.1% on Monday . The stock traded as high as C$0.15 and last traded at C$0.15. Approximately 473,147 shares were traded during mid-day trading, a decline of 68% from the average daily volume of 1,480,179 shares. The stock had previously closed at C$0.14.
GeneNews Stock Performance
The business’s 50-day moving average price is C$0.15. The company has a market cap of C$25.49 million and a PE ratio of -2.21.
GeneNews Company Profile
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Recommended Stories
- Five stocks we like better than GeneNews
- What is the FTSE 100 index?
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- How to Use the MarketBeat Dividend Calculator
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- What Are Dividend Challengers?
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.